查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1451864

2024-2032 年按產品、使用類型、價格範圍、應用、最終用戶和地區分類的血液分析儀和試劑市場報告

Hematology Analyzers and Reagents Market Report by Product, Usage Type, Price Range, Application, End User, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 146 Pages | 商品交期: 2-3個工作天內

價格

2023年，全球血液分析儀和試劑市場規模達到88億美元。展望未來， IMARC Group預計到2032年市場規模將達到150億美元，2024-2032年複合年成長率（CAGR）為5.94%。血液疾病盛行率上升、老年人口不斷增加、技術快速進步、對即時檢測(POCT) 設備和攜帶式血液分析儀的需求激增，以及實驗室和醫院擴大採用自動化血液分析儀，這些都是其中的一些因素。推動市場的關鍵因素。

血液分析儀和試劑在現代醫學診斷中發揮著至關重要的作用，能夠準確、有效率地評估血液樣本。它們旨在分析各種血液參數並提供有關患者健康狀況的寶貴見解。血液分析儀由幾個關鍵組件組成，包括樣本處理系統、流體系統、細胞計數和分化系統以及資料處理單元。與這些分析儀結合使用的試劑有助於促進特定血液成分的檢測和測量。血液分析儀在臨床環境中具有多種優勢，例如可以快速提供結果，從而可以及時做出診斷和治療決策。此外，它們還提供高水準的準確性和精確度，最大限度地降低診斷錯誤的風險。它們能夠分析各種血液參數，包括全血球計數 (CBC)、白血球分類和血紅蛋白水平。目前，有不同類型的血液分析儀可供選擇，從緊湊型桌上型型號到大型全自動系統。

血液分析儀和試劑市場趨勢：

全球血液分析儀和試劑市場的成長主要受到幾個關鍵因素的推動，包括貧血、白血病和血友病等血液疾病盛行率的上升。此外，老年人口的成長和技術的快速進步，例如血液分析儀中人工智慧（AI）和機器學習（ML）演算法的整合，正在推動市場成長。此外，實驗室和醫院擴大採用自動化血液分析儀，提供快速、精確的結果，正在推動市場成長。人們對早期疾病檢測和預防性醫療措施的重要性的認知不斷提高，以及對即時檢測（POC​​T）設備和攜帶式血液分析儀的需求激增，是促進市場成長的其他因素。與此一致的是，血液學研發（R＆D）活動的​​支出激增，重點是開發新型試劑和分析儀，正在推動市場成長。此外，主要參與者之間為增強產品組合和擴大地理影響力而進行的策略合作和夥伴關係也有利於市場成長。

本報告回答的關鍵問題：

  • 迄今為止，全球血液分析儀和試劑市場表現如何，未來幾年將如何表現？
  • 全球血液分析儀和試劑市場的促進因素、限制因素和機會是什麼？
  • 每個促進因素、限制因素和機會對全球血液分析儀和試劑市場有何影響？
  • 主要區域市場有哪些？
  • 哪些國家代表了最具吸引力的血液分析儀和試劑市場？
  • 基於產品的市場區隔是什麼？
  • 血液分析儀和試劑市場中最具吸引力的產品是什麼？
  • 根據使用類型分類的市場是怎麼樣的？
  • 血液分析儀和試劑市場中哪種使用類型最具吸引力？
  • 依價格範圍分類的市場是怎麼樣的？
  • 血液分析儀和試劑市場中哪個價格範圍最具吸引力？
  • 基於應用的市場區隔是怎樣的？
  • 血液分析儀和試劑市場中最具吸引力的應用是什麼？
  • 基於最終用戶的市場區隔是什麼？
  • 血液分析儀和試劑市場中哪一個對最終用戶最具吸引力？
  • 全球血液分析儀及試劑市場競爭格局如何？
  • 全球血液分析儀和試劑市場的主要參與者/公司有哪些？

目錄

第1章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 資料來源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球血液分析儀與試劑市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場預測

第 6 章：市場區隔：依產品

  • 血液學
    • 市場走向
    • 市場預測
  • 止血
    • 市場走向
    • 市場預測
  • 免疫血液學
    • 市場走向
    • 市場預測

第 7 章：市場區隔：按使用類型

  • 獨立式
    • 市場走向
    • 市場預測
  • 現場護理
    • 市場走向
    • 市場預測

第 8 章：市場區隔：依價格範圍

  • 低量程
    • 市場走向
    • 市場預測
  • 中檔
    • 市場走向
    • 市場預測
  • 高範圍
    • 市場走向
    • 市場預測

第 9 章：市場區隔：按應用

  • 出血性疾病
    • 市場走向
    • 市場預測
  • 感染相關病症
    • 市場走向
    • 市場預測
  • 免疫系統相關病症
    • 市場走向
    • 市場預測
  • 血癌
    • 市場走向
    • 市場預測
  • 貧血
    • 市場走向
    • 市場預測

第 10 章：市場區隔：依最終用戶

  • 商業服務提供者
    • 市場走向
    • 市場預測
  • 醫院實驗室
    • 市場走向
    • 市場預測
  • 研究和學術機構
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 11 章：市場區隔：按地區

  • 北美洲
    • 美國
      • 市場走向
      • 市場預測
    • 加拿大
      • 市場走向
      • 市場預測
  • 亞太
    • 中國
      • 市場走向
      • 市場預測
    • 日本
      • 市場走向
      • 市場預測
    • 印度
      • 市場走向
      • 市場預測
    • 韓國
      • 市場走向
      • 市場預測
    • 澳洲
      • 市場走向
      • 市場預測
    • 印尼
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 歐洲
    • 德國
      • 市場走向
      • 市場預測
    • 法國
      • 市場走向
      • 市場預測
    • 英國
      • 市場走向
      • 市場預測
    • 義大利
      • 市場走向
      • 市場預測
    • 西班牙
      • 市場走向
      • 市場預測
    • 俄羅斯
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 拉丁美洲
    • 巴西
      • 市場走向
      • 市場預測
    • 墨西哥
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 中東和非洲
    • 市場走向
    • 市場細分：按國家/地區
    • 市場預測

第 12 章：促進因素、限制與機會

  • 概述
  • 促進要素
  • 限制
  • 機會

第 13 章：價值鏈分析

第 14 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 15 章：價格分析

第16章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Abbott Laboratories
    • Bio-Rad Laboratories Inc.
    • Boule Diagnostics
    • Danaher Corporation
    • Diatron MI PLC (Stratec SE)
    • EKF Diagnostics Holdings plc
    • Heska Corporation
    • Horiba Ltd.
    • Mindray Medical International Limited
    • Nihon Kohden Corporation
    • Siemens
    • Sinnowa Medical Science & Technology Co. Ltd.
Product Code: SR112024A8300

The global hematology analyzers and reagents market size reached US$ 8.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 15.0 Billion by 2032, exhibiting a growth rate (CAGR) of 5.94% during 2024-2032. Rising prevalence of blood disorders, the growing geriatric population, rapid advancements in technology, surging demand for point-of-care testing (POCT) devices and portable hematology analyzers, and the increasing adoption of automated hematology analyzers in laboratories and hospitals are some of the key factors driving the market.

Hematology analyzers and reagents play a crucial role in modern medical diagnostics, enabling the accurate and efficient assessment of blood samples. They are designed to analyze various blood parameters and provide valuable insights into a patient's health. Hematology analyzers consist of several key components, including a sample handling system, a fluidics system, a cell counting and differentiation system, and a data processing unit. Reagents used in conjunction with these analyzers help facilitate the detection and measurement of specific blood components. Hematology analyzers offer several advantages in clinical settings, such as they provide rapid results, allowing for timely diagnosis and treatment decisions. Additionally, they offer high levels of accuracy and precision, minimizing the risk of diagnostic errors. They are capable of analyzing a wide range of blood parameters, including complete blood count (CBC), white blood cell differential, and hemoglobin levels. Currently, there are different types of hematology analyzers available, ranging from compact benchtop models to larger, fully automated systems.

Hematology Analyzers and Reagents Market Trends:

The global hematology analyzers and reagents market is primarily accelerated by several key factors, including the rising prevalence of blood disorders, such as anemia, leukemia, and hemophilia. Moreover, the growing geriatric population and rapid advancements in technology, such as the integration of artificial intelligence (AI) and machine learning (ML) algorithms in hematology analyzers, are driving the market growth. Additionally, the increasing adoption of automated hematology analyzers in laboratories and hospitals, which offer rapid and precise results, is propelling the market growth. The escalating awareness about the importance of early disease detection and preventive healthcare measures and the surging demand for point-of-care testing (POCT) devices and portable hematology analyzers are other factors contributing to the market growth. In line with this, the surging expenditure in research and development (R&D) activities in hematology, focusing on the development of novel reagents and analyzers, is fueling the market growth. Furthermore, strategic collaborations and partnerships among key players to enhance their product portfolios and expand their geographical presence are favoring the market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global hematology analyzers and reagents market, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on product, usage type, price range, application, and end user.

Product Insights:

Haematology

Haemostasis

Immunohaematology

The report has provided a detailed breakup and analysis of the hematology analyzers and reagents market based on the product. This includes haematology, haemostasis, and immunohaematology. According to the report, haematology represented the largest segment.

Usage Type Insights:

Standalone

Point-of-Care

A detailed breakup and analysis of the hematology analyzers and reagents market based on the usage type has also been provided in the report. This includes standalone and point-of-care. According to the report, standalone accounted for the largest market share.

Price Range Insights:

Low Range

Mid-Range

High Range

The report has provided a detailed breakup and analysis of the hematology analyzers and reagents market based on the price range. This includes low range, mid-range, and high range. According to the report, low range represented the largest segment.

Application Insights:

Haemorrhagic Conditions

Infection-Related Conditions

Immune System-Related Conditions

Blood Cancer

Anaemia

A detailed breakup and analysis of the hematology analyzers and reagents market based on the application has also been provided in the report. This includes haemorrhagic conditions, infection-related conditions, immune system-related conditions, blood cancer, and anaemia. According to the report, haemorrhagic conditions accounted for the largest market share.

End User Insights:

Commercial Service Providers

Hospital Laboratories

Research and Academic Institutes

Others

The report has provided a detailed breakup and analysis of the hematology analyzers and reagents market based on the end user. This includes commercial service providers, hospital laboratories, research and academic institutes, and others. According to the report, commercial service providers represented the largest segment.

Regional Insights:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for hematology analyzers and reagents. Some of the factors driving the North America hematology analyzers and reagents market included the surging demand for personalized medicine and companion diagnostics, the increasing number of clinical trials and drug development activities, and the rising demand for hematology analyzers and reagents in veterinary diagnostics.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global hematology analyzers and reagents market. Detailed profiles of all major companies have been provided. Some of the companies covered include Abbott Laboratories, Bio-Rad Laboratories Inc., Boule Diagnostics, Danaher Corporation, Diatron MI PLC (Stratec SE), EKF Diagnostics Holdings plc, Heska Corporation, Horiba Ltd., Mindray Medical International Limited, Nihon Kohden Corporation, Siemens, Sinnowa Medical Science & Technology Co. Ltd., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:

  • How has the global hematology analyzers and reagents market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global hematology analyzers and reagents market?
  • What is the impact of each driver, restraint, and opportunity on the global hematology analyzers and reagents market?
  • What are the key regional markets?
  • Which countries represent the most attractive hematology analyzers and reagents market?
  • What is the breakup of the market based on product?
  • Which is the most attractive product in the hematology analyzers and reagents market?
  • What is the breakup of the market based on the usage type?
  • Which is the most attractive usage type in the hematology analyzers and reagents market?
  • What is the breakup of the market based on price range?
  • Which is the most attractive price range in the hematology analyzers and reagents market?
  • What is the breakup of the market based on application?
  • Which is the most attractive application in the hematology analyzers and reagents market?
  • What is the breakup of the market based on end user?
  • Which is the most attractive end user in the hematology analyzers and reagents market?
  • What is the competitive structure of the global hematology analyzers and reagents market?
  • Who are the key players/companies in the global hematology analyzers and reagents market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Hematology Analyzers and Reagents Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Haematology
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Haemostasis
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Immunohaematology
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Usage Type

  • 7.1 Standalone
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Point-of-Care
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Price Range

  • 8.1 Low Range
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Mid-Range
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 High Range
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Application

  • 9.1 Haemorrhagic Conditions
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Infection-Related Conditions
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Immune System-Related Conditions
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Blood Cancer
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast
  • 9.5 Anaemia
    • 9.5.1 Market Trends
    • 9.5.2 Market Forecast

10 Market Breakup by End User

  • 10.1 Commercial Service Providers
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Hospital Laboratories
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Research and Academic Institutes
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast
  • 10.4 Others
    • 10.4.1 Market Trends
    • 10.4.2 Market Forecast

11 Market Breakup by Region

  • 11.1 North America
    • 11.1.1 United States
      • 11.1.1.1 Market Trends
      • 11.1.1.2 Market Forecast
    • 11.1.2 Canada
      • 11.1.2.1 Market Trends
      • 11.1.2.2 Market Forecast
  • 11.2 Asia-Pacific
    • 11.2.1 China
      • 11.2.1.1 Market Trends
      • 11.2.1.2 Market Forecast
    • 11.2.2 Japan
      • 11.2.2.1 Market Trends
      • 11.2.2.2 Market Forecast
    • 11.2.3 India
      • 11.2.3.1 Market Trends
      • 11.2.3.2 Market Forecast
    • 11.2.4 South Korea
      • 11.2.4.1 Market Trends
      • 11.2.4.2 Market Forecast
    • 11.2.5 Australia
      • 11.2.5.1 Market Trends
      • 11.2.5.2 Market Forecast
    • 11.2.6 Indonesia
      • 11.2.6.1 Market Trends
      • 11.2.6.2 Market Forecast
    • 11.2.7 Others
      • 11.2.7.1 Market Trends
      • 11.2.7.2 Market Forecast
  • 11.3 Europe
    • 11.3.1 Germany
      • 11.3.1.1 Market Trends
      • 11.3.1.2 Market Forecast
    • 11.3.2 France
      • 11.3.2.1 Market Trends
      • 11.3.2.2 Market Forecast
    • 11.3.3 United Kingdom
      • 11.3.3.1 Market Trends
      • 11.3.3.2 Market Forecast
    • 11.3.4 Italy
      • 11.3.4.1 Market Trends
      • 11.3.4.2 Market Forecast
    • 11.3.5 Spain
      • 11.3.5.1 Market Trends
      • 11.3.5.2 Market Forecast
    • 11.3.6 Russia
      • 11.3.6.1 Market Trends
      • 11.3.6.2 Market Forecast
    • 11.3.7 Others
      • 11.3.7.1 Market Trends
      • 11.3.7.2 Market Forecast
  • 11.4 Latin America
    • 11.4.1 Brazil
      • 11.4.1.1 Market Trends
      • 11.4.1.2 Market Forecast
    • 11.4.2 Mexico
      • 11.4.2.1 Market Trends
      • 11.4.2.2 Market Forecast
    • 11.4.3 Others
      • 11.4.3.1 Market Trends
      • 11.4.3.2 Market Forecast
  • 11.5 Middle East and Africa
    • 11.5.1 Market Trends
    • 11.5.2 Market Breakup by Country
    • 11.5.3 Market Forecast

12 Drivers, Restraints, and Opportunities

  • 12.1 Overview
  • 12.2 Drivers
  • 12.3 Restraints
  • 12.4 Opportunities

13 Value Chain Analysis

14 Porters Five Forces Analysis

  • 14.1 Overview
  • 14.2 Bargaining Power of Buyers
  • 14.3 Bargaining Power of Suppliers
  • 14.4 Degree of Competition
  • 14.5 Threat of New Entrants
  • 14.6 Threat of Substitutes

15 Price Analysis

16 Competitive Landscape

  • 16.1 Market Structure
  • 16.2 Key Players
  • 16.3 Profiles of Key Players
    • 16.3.1 Abbott Laboratories
      • 16.3.1.1 Company Overview
      • 16.3.1.2 Product Portfolio
    • 16.3.2 Bio-Rad Laboratories Inc.
      • 16.3.2.1 Company Overview
      • 16.3.2.2 Product Portfolio
    • 16.3.3 Boule Diagnostics
      • 16.3.3.1 Company Overview
      • 16.3.3.2 Product Portfolio
    • 16.3.4 Danaher Corporation
      • 16.3.4.1 Company Overview
      • 16.3.4.2 Product Portfolio
    • 16.3.5 Diatron MI PLC (Stratec SE)
      • 16.3.5.1 Company Overview
      • 16.3.5.2 Product Portfolio
    • 16.3.6 EKF Diagnostics Holdings plc
      • 16.3.6.1 Company Overview
      • 16.3.6.2 Product Portfolio
    • 16.3.7 Heska Corporation
      • 16.3.7.1 Company Overview
      • 16.3.7.2 Product Portfolio
    • 16.3.8 Horiba Ltd.
      • 16.3.8.1 Company Overview
      • 16.3.8.2 Product Portfolio
    • 16.3.9 Mindray Medical International Limited
      • 16.3.9.1 Company Overview
      • 16.3.9.2 Product Portfolio
    • 16.3.10 Nihon Kohden Corporation
      • 16.3.10.1 Company Overview
      • 16.3.10.2 Product Portfolio
    • 16.3.11 Siemens
      • 16.3.11.1 Company Overview
      • 16.3.11.2 Product Portfolio
      • 16.3.11.3 Financials
    • 16.3.12 Sinnowa Medical Science & Technology Co. Ltd.
      • 16.3.12.1 Company Overview
      • 16.3.12.2 Product Portfolio

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

List of Figures

  • Figure 1: Global: Hematology Analyzers and Reagents Market: Major Drivers and Challenges
  • Figure 2: Global: Hematology Analyzers and Reagents Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Hematology Analyzers and Reagents Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Hematology Analyzers and Reagents Market: Breakup by Product (in %), 2023
  • Figure 5: Global: Hematology Analyzers and Reagents Market: Breakup by Usage Type (in %), 2023
  • Figure 6: Global: Hematology Analyzers and Reagents Market: Breakup by Price Range (in %), 2023
  • Figure 7: Global: Hematology Analyzers and Reagents Market: Breakup by Application (in %), 2023
  • Figure 8: Global: Hematology Analyzers and Reagents Market: Breakup by End User (in %), 2023
  • Figure 9: Global: Hematology Analyzers and Reagents Market: Breakup by Region (in %), 2023
  • Figure 10: Global: Hematology Analyzers and Reagents (Haematology) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Hematology Analyzers and Reagents (Haematology) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Hematology Analyzers and Reagents (Haemostasis) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Hematology Analyzers and Reagents (Haemostasis) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Hematology Analyzers and Reagents (Immunohaematology) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Hematology Analyzers and Reagents (Immunohaematology) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Hematology Analyzers and Reagents (Standalone) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Hematology Analyzers and Reagents (Standalone) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Hematology Analyzers and Reagents (Point-of-care) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Hematology Analyzers and Reagents (Point-of-care) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Hematology Analyzers and Reagents (Low Range) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Hematology Analyzers and Reagents (Low Range) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Hematology Analyzers and Reagents (Mid-Range) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Hematology Analyzers and Reagents (Mid-Range) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Hematology Analyzers and Reagents (High Range) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Hematology Analyzers and Reagents (High Range) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Hematology Analyzers and Reagents (Haemorrhagic Conditions) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Hematology Analyzers and Reagents (Haemorrhagic Conditions) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Hematology Analyzers and Reagents (Infection-Related Conditions) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Hematology Analyzers and Reagents (Infection-Related Conditions) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: Hematology Analyzers and Reagents (Immune System-Related Conditions) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: Hematology Analyzers and Reagents (Immune System-Related Conditions) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Global: Hematology Analyzers and Reagents (Blood Cancer) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Global: Hematology Analyzers and Reagents (Blood Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Global: Hematology Analyzers and Reagents (Anaemia) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Global: Hematology Analyzers and Reagents (Anaemia) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Global: Hematology Analyzers and Reagents (Commercial Service Providers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Global: Hematology Analyzers and Reagents (Commercial Service Providers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Global: Hematology Analyzers and Reagents (Hospital Laboratories) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Global: Hematology Analyzers and Reagents (Hospital Laboratories) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: Global: Hematology Analyzers and Reagents (Research and Academic Institutes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: Global: Hematology Analyzers and Reagents (Research and Academic Institutes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Global: Hematology Analyzers and Reagents (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Global: Hematology Analyzers and Reagents (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: North America: Hematology Analyzers and Reagents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: North America: Hematology Analyzers and Reagents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: United States: Hematology Analyzers and Reagents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: United States: Hematology Analyzers and Reagents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Canada: Hematology Analyzers and Reagents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Canada: Hematology Analyzers and Reagents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Asia-Pacific: Hematology Analyzers and Reagents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Asia-Pacific: Hematology Analyzers and Reagents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: China: Hematology Analyzers and Reagents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: China: Hematology Analyzers and Reagents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Japan: Hematology Analyzers and Reagents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Japan: Hematology Analyzers and Reagents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: India: Hematology Analyzers and Reagents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: India: Hematology Analyzers and Reagents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: South Korea: Hematology Analyzers and Reagents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: South Korea: Hematology Analyzers and Reagents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Australia: Hematology Analyzers and Reagents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Australia: Hematology Analyzers and Reagents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Indonesia: Hematology Analyzers and Reagents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Indonesia: Hematology Analyzers and Reagents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Others: Hematology Analyzers and Reagents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Others: Hematology Analyzers and Reagents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Europe: Hematology Analyzers and Reagents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Europe: Hematology Analyzers and Reagents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Germany: Hematology Analyzers and Reagents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Germany: Hematology Analyzers and Reagents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: France: Hematology Analyzers and Reagents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: France: Hematology Analyzers and Reagents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: United Kingdom: Hematology Analyzers and Reagents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: United Kingdom: Hematology Analyzers and Reagents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Italy: Hematology Analyzers and Reagents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Italy: Hematology Analyzers and Reagents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Spain: Hematology Analyzers and Reagents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Spain: Hematology Analyzers and Reagents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: Russia: Hematology Analyzers and Reagents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 79: Russia: Hematology Analyzers and Reagents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 80: Others: Hematology Analyzers and Reagents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 81: Others: Hematology Analyzers and Reagents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 82: Latin America: Hematology Analyzers and Reagents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 83: Latin America: Hematology Analyzers and Reagents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 84: Brazil: Hematology Analyzers and Reagents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 85: Brazil: Hematology Analyzers and Reagents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 86: Mexico: Hematology Analyzers and Reagents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 87: Mexico: Hematology Analyzers and Reagents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 88: Others: Hematology Analyzers and Reagents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 89: Others: Hematology Analyzers and Reagents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 90: Middle East and Africa: Hematology Analyzers and Reagents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 91: Middle East and Africa: Hematology Analyzers and Reagents Market: Breakup by Country (in %), 2023
  • Figure 92: Middle East and Africa: Hematology Analyzers and Reagents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 93: Global: Hematology Analyzers and Reagents Industry: Drivers, Restraints, and Opportunities
  • Figure 94: Global: Hematology Analyzers and Reagents Industry: Value Chain Analysis
  • Figure 95: Global: Hematology Analyzers and Reagents Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Hematology Analyzers and Reagents Market: Key Industry Highlights, 2023 & 2032
  • Table 2: Global: Hematology Analyzers and Reagents Market Forecast: Breakup by Product (in Million US$), 2024-2032
  • Table 3: Global: Hematology Analyzers and Reagents Market Forecast: Breakup by Usage Type (in Million US$), 2024-2032
  • Table 4: Global: Hematology Analyzers and Reagents Market Forecast: Breakup by Price Range (in Million US$), 2024-2032
  • Table 5: Global: Hematology Analyzers and Reagents Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 6: Global: Hematology Analyzers and Reagents Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 7: Global: Hematology Analyzers and Reagents Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 8: Global: Hematology Analyzers and Reagents Market: Competitive Structure
  • Table 9: Global: Hematology Analyzers and Reagents Market: Key Players